{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:43:53Z","timestamp":1785368633755,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Benign prostatic hyperplasia (BPH) is an affliction of the aging male population that contributes to bothersome and disruptive lower urinary tract symptoms (LUTS). The UroLift\u00ae implant has been developed as a mechanical means of widening the prostatic urethra and providing relief from lower urinary tract symptoms (LUTS) through a minimally invasive procedure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the current study, we utilize histological results from canine tissue, resected tissue from human subjects treated with the UroLift System and post-market surveillance data collected by the manufacturer in order to elucidate the long-term biological mechanism of action of the UroLift implant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The delivery of the implant causes tissue compression, likely resulting in focal ischemia that causes observed local atrophy and minimal-mild chronic inflammation that ultimately remodels tissue to produce a widened prostatic urethra.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These studies reveal the lack of impact the device has on systemic tissue, providing evidence that the UroLift System is benign and biocompatible, and offering histologic explanation for the clinically observed durability.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41391-021-00434-0","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T13:10:24Z","timestamp":1628255424000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The UroLift implant: mechanism behind rapid and durable relief from prostatic obstruction"],"prefix":"10.1038","volume":"25","author":[{"given":"Claus G.","family":"Roehrborn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-6606","authenticated-orcid":false,"given":"Peter T.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4099-0339","authenticated-orcid":false,"given":"Henry H.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"434_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5213\/inj.2013.17.3.98","volume":"17","author":"YH Joung","year":"2013","unstructured":"Joung YH. Development of implantable medical devices: from an engineering perspective. Int Neurourol J. 2013;17:98\u2013106.","journal-title":"Int Neurourol J"},{"key":"434_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0002-9394(14)74042-5","volume":"114","author":"CM Sharkness","year":"1992","unstructured":"Sharkness CM, Hamburger S, Kaczmarek RG, Hamilton PM, Bright RA, Moore RM Jr. Racial differences in the prevalence of intraocular lens implants in the United States. Am J Ophthalmol. 1992;114:667\u201374.","journal-title":"Am J Ophthalmol"},{"key":"434_CR3","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/lary.20859","volume":"120","author":"BR Peters","year":"2010","unstructured":"Peters BR, Wyss J, Manrique M. Worldwide trends in bilateral cochlear implantation. Laryngoscope. 2010;120:S17\u201344.","journal-title":"Laryngoscope"},{"key":"434_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jvs.2017.09.046","volume":"67","author":"BD Suckow","year":"2018","unstructured":"Suckow BD, Goodney PP, Columbo JA, Kang R, Stone DH, Sedrakyan A, et al. National trends in open surgical, endovascular, and branched-fenestrated endovascular aortic aneurysm repair in Medicare patients. J Vasc Surg. 2018;67:1690\u20137. e1","journal-title":"J Vasc Surg"},{"key":"434_CR5","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1097\/01.ju.0000134888.22332.bb","volume":"172","author":"KA Roehl","year":"2004","unstructured":"Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172:910\u20134.","journal-title":"J Urol"},{"key":"434_CR6","first-page":"236","volume":"19","author":"KM Fabian","year":"1980","unstructured":"Fabian KM. [The intra-prostatic \u201cpartial catheter\u201d (urological spiral) (author\u2019s transl)]. Urol A. 1980;19:236\u20138.","journal-title":"Urol A"},{"key":"434_CR7","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.juro.2007.01.005","volume":"177","author":"JN Armitage","year":"2007","unstructured":"Armitage JN, Cathcart PJ, Rashidian A, De Nigris E, Emberton M, van der Meulen JH. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature. J Urol. 2007;177:1619\u201324.","journal-title":"J Urol"},{"key":"434_CR8","first-page":"75","volume":"22","author":"CC Peyton","year":"2015","unstructured":"Peyton CC, Badlani GH. The management of prostatic obstruction with urethral stents. Can J Urol. 2015;22:75\u201381.","journal-title":"Can J Urol"},{"key":"434_CR9","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.juro.2013.05.116","volume":"190","author":"CG Roehrborn","year":"2013","unstructured":"Roehrborn CG, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190:2161\u20137.","journal-title":"J Urol"},{"key":"434_CR10","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24:8802\u201313.","journal-title":"Can J Urol"},{"key":"434_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.urology.2011.10.021","volume":"79","author":"PT Chin","year":"2012","unstructured":"Chin PT, Bolton DM, Jack G, Rashid P, Thavaseelan J, Yu RJ, et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012;79:5\u201311.","journal-title":"Urology"},{"key":"434_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1089\/end.2019.0167","volume":"33","author":"G Eure","year":"2019","unstructured":"Eure G, Gange S, Walter P, Khan A, Chabert C, Mueller T, et al. Real-world evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a retrospective multicenter study. J Endourol. 2019;33:576\u201384.","journal-title":"J Endourol"},{"key":"434_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/bju.13666","volume":"118","author":"D Rukstalis","year":"2016","unstructured":"Rukstalis D, Rashid P, Bogache WK, Tutrone RF, Barkin J, Chin PT, et al. 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham. BJU Int. 2016;118:14\u201322.","journal-title":"BJU Int"},{"key":"434_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","volume":"68","author":"J S\u00f8nksen","year":"2015","unstructured":"S\u00f8nksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643\u201352.","journal-title":"Eur Urol"},{"key":"434_CR15","first-page":"7772","volume":"22","author":"CG Roehrborn","year":"2015","unstructured":"Roehrborn CG, Rukstalis DB, Barkin J, Gange SN, Shore ND, Giddens JL, et al. Three year results of the prostatic urethral L.I.F.T. study. Can J Urol. 2015;22:7772\u201382.","journal-title":"Can J Urol"},{"key":"434_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00345-018-2494-1","volume":"37","author":"KD Sievert","year":"2019","unstructured":"Sievert KD, Schonthaler M, Berges R, Toomey P, Drager D, Herlemann A, et al. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol. 2019;37:1353\u201360.","journal-title":"World J Urol"},{"key":"434_CR17","unstructured":"FDA U. Biological responses to metal implants. Food and Drug Administration. 2019:1\u2013143. https:\/\/www.fda.gov\/media\/131150\/download Accessed 21 Jan 2021."},{"key":"434_CR18","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1002\/jbm.b.33734","volume":"105","author":"E Gibon","year":"2017","unstructured":"Gibon E, Amanatullah DF, Loi F, Pajarinen J, Nabeshima A, Yao Z, et al. The biological response to orthopaedic implants for joint replacement: Part I: Metals. J Biomed Mater Res B Appl Biomater. 2017;105:2162\u201373.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"434_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41391-018-0118-x","volume":"22","author":"D Rukstalis","year":"2019","unstructured":"Rukstalis D, Grier D, Stroup SP, Tutrone R, deSouza E, Freedman S, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019;22:411\u20139.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"434_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1743-6109.2011.02568.x","volume":"9","author":"HH Woo","year":"2012","unstructured":"Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012;9:568\u201375.","journal-title":"J Sex Med"},{"key":"434_CR21","doi-asserted-by":"crossref","unstructured":"Hoffman RM, Monga M, Elliott SP, Macdonald R, Langsjoen J, Tacklind J, et al. Microwave thermotherapy for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2012;9:CD004135.","DOI":"10.1002\/14651858.CD004135.pub3"},{"key":"434_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1046\/j.1464-410X.1997.00414.x","volume":"80","author":"DJ Rosario","year":"1997","unstructured":"Rosario DJ, Woo H, Potts KL, Cutinha PE, Hastie KJ, Chapple CR. Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol. 1997;80:579\u201386.","journal-title":"Br J Urol"},{"key":"434_CR23","first-page":"10213","volume":"27","author":"RF Tutrone","year":"2020","unstructured":"Tutrone RF, Schiff W. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection. Can J Urol. 2020;27:10213\u20139.","journal-title":"Can J Urol"},{"key":"434_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.eururo.2010.04.027","volume":"58","author":"F Bruyere","year":"2010","unstructured":"Bruyere F, Puichaud A, Pereira H, Faivre d\u2019Arcier B, Rouanet A, Floc\u2019h AP, et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol. 2010;58:207\u201311.","journal-title":"Eur Urol"},{"key":"434_CR25","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195:1529\u201338.","journal-title":"J Urol"},{"key":"434_CR26","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)\u2013incidence, management, and prevention. Eur Urol. 2006;50:969\u201379. discussion 80","journal-title":"Eur Urol"},{"key":"434_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.juro.2014.09.001","volume":"193","author":"A Bachmann","year":"2015","unstructured":"Bachmann A, Tubaro A, Barber N, d\u2019Ancona F, Muir G, Witzsch U, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015;193:570\u20138.","journal-title":"J Urol"},{"key":"434_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1464-410X.1995.tb07224.x","volume":"75","author":"DC Hanbury","year":"1995","unstructured":"Hanbury DC, Sethia KK. Erectile function following transurethral prostatectomy. Br J Urol. 1995;75:12\u20133.","journal-title":"Br J Urol"},{"key":"434_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.eururo.2013.02.026","volume":"64","author":"B Lukacs","year":"2013","unstructured":"Lukacs B, Cornu JN, Aout M, Tessier N, Hod\u00e9e C, Haab F, et al. Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. Eur Urol. 2013;64:493\u2013501.","journal-title":"Eur Urol"},{"key":"434_CR30","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1089\/end.2011.0370","volume":"26","author":"S Malde","year":"2012","unstructured":"Malde S, Rajagopalan A, Patel N, Simoes A, Choi W, Shrotri N. Potassium-titanyl-phosphate laser photoselective vaporization for benign prostatic hyperplasia: 5-year follow-up from a district general hospital. J Endourol. 2012;26:878\u201383.","journal-title":"J Endourol"},{"key":"434_CR31","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1089\/end.2016.0522","volume":"30","author":"Y Yamada","year":"2016","unstructured":"Yamada Y, Furusawa J, Sugimura Y, Kuromatsu I. Photoselective vaporization of the prostate: long-term outcomes and safety during 10 years of follow-up. J Endourol. 2016;30:1306\u201311.","journal-title":"J Endourol"},{"key":"434_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2147\/OAJU.S11752","volume":"3","author":"AG Papatsoris","year":"2011","unstructured":"Papatsoris AG, Junaid I, Zachou A, Kachrilas S, Zaman F, Masood J, et al. New developments in the use of prostatic stents. Open Access J Urol. 2011;3:63\u20138.","journal-title":"Open Access J Urol"}],"updated-by":[{"DOI":"10.1038\/s41391-021-00457-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000}}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00434-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00434-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T11:07:35Z","timestamp":1650452855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-021-00434-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["434"],"URL":"https:\/\/doi.org\/10.1038\/s41391-021-00434-0","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41391-021-00457-7","asserted-by":"object"}]},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"assertion":[{"value":"12 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41391-021-00457-7","URL":"https:\/\/doi.org\/10.1038\/s41391-021-00457-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Drs. Chin and Roehrborn are NeoTract Inc.\/Teleflex consultants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}